Teresa Mattarelli
Corporate Officer/Principal presso Perspectum Group Ltd.
Profilo
Teresa Mattarelli is currently the Chief Commercial Officer at Perspectum Group Ltd.
Prior to this, she worked at Medtronic Plc as the Global Vice President & General Manager from 2019 to 2020.
She completed her undergraduate degree and MBA from McGill University.
Posizioni attive di Teresa Mattarelli
| Società | Posizione | Inizio |
|---|---|---|
Perspectum Group Ltd.
 Perspectum Group Ltd. Packaged SoftwareTechnology Services Perspectum Group Plc engages in the sale of diagnostic products via a software-as-a-medical device platform. Its products combine expertise in image formation, magnetic resonance image analysis and artificial intelligence to support healthcare provider diagnosis, treatment decision-making, and monitoring of the progression of chronic metabolic diseases, multi-organ pathologies and cancer, and determine whether the patient is responding to therapy. Its products include Liver MultiScan, MRCP+, Hepatica, and CoverScan MD. The company was founded by Matthew Robson on June 10, 2021 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | 01/02/2021 |
Precedenti posizioni note di Teresa Mattarelli
| Società | Posizione | Fine |
|---|---|---|
| MEDTRONIC PLC | Corporate Officer/Principal | 01/11/2020 |
Formazione di Teresa Mattarelli
| McGill University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| MEDTRONIC PLC | Health Technology |
| Aziende private | 1 |
|---|---|
Perspectum Group Ltd.
Perspectum Group Ltd. Packaged SoftwareTechnology Services Perspectum Group Plc engages in the sale of diagnostic products via a software-as-a-medical device platform. Its products combine expertise in image formation, magnetic resonance image analysis and artificial intelligence to support healthcare provider diagnosis, treatment decision-making, and monitoring of the progression of chronic metabolic diseases, multi-organ pathologies and cancer, and determine whether the patient is responding to therapy. Its products include Liver MultiScan, MRCP+, Hepatica, and CoverScan MD. The company was founded by Matthew Robson on June 10, 2021 and is headquartered in Oxford, the United Kingdom. | Technology Services |
- Borsa valori
- Insiders
- Teresa Mattarelli